Metronidazole and drug resistance

doi:10.1016/0169-4758(93)90143-4

Parasitology Today

Volume 9, Issue 5, May 1993, Pages 183-186

Parasitology Today

https://doi.org/10.1016/0169-4758(93)90143-4 Get rights and content

Abstract

In recent years, the basis of metronidozole resistance has been examined in anaerobic protozoa, such as Trichomonas and Giardia, as well as anaerobic bacteria, such as Bacteroides and Clostridium. In this review, Patricia Johnson looks at a variety of mechanisms that lead to reduced susceptibility of these pathogens to the drug. The frequent correlation between metronidozole resistance and inefficient drug activation suggests that this is the level at which drug resistance operates.

References (50)

R.M.J. Ings et al.
Biochem. Pharmacol.
(1974)
M. Muller
Biochem. Pharmacol.
(1986)
N. Yarlett
Mol. Biochem. Parasitol.
(1985)
A. Cerkasovova et al.
Mol. Biochem. Parasitol.
(1984)
N. Yarlett et al.
Biochem. Pharmacol.
(1986)
D. Lloyd et al.
Biochem. Pharmacol.
(1986)
D.L. Church et al.
Biochem. Pharmacol.
(1988)
E. Knight et al.
J. Biol. Chem.
(1967)
S.N.J. Moreno
J. Biol. Chem.
(1983)
S.N.J. Moreno et al.
J. Biol, Chem.
(1984)

J. Breuil

Plasmid

(1989)

G.U. Wehnert

Plasmid

(1990)

N.C. Smith et al.

Internatl J. Parasitol.

(1988)

N. Yarlett et al.

Mol. Biochem. Parasitol.

(1986)

S.J. Foote

Cell

(1989)

H.L. Callahan et al.

J. Biol. Chem.

(1991)

J. Samuelson

Mol. Biochem. Parasitol.

(1990)

A.M. van der Bliek et al.

Adv. Cancer Res.

(1989)

M. Muller

Surgery

(1983)

V.L. Sutter

M. Sebald et al.

A.C. Begg et al.

Br. J. Radial.

(1974)

J. Denekamp et al.

Radiat. Res.

(1974)

J.W. Smith et al.

Annu. Rev. Med.

(1980)

C.M. Beard

N. Engl. J. Med.

(1979)

Cited by (115)

Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies
2020, Bioorganic Chemistry
A series of thiadiazino[5,6-b]quinoxaline and thiazolo[4,5-b]quinoxaline derivatives was designed and synthetized from the reaction of 2,3-dichloro-6-(morpholinosulfonyl)quinoxaline (2) with thiosemicarbazide or thiocarbohydrazide and thiourea derivatives to give nineteen quinoxaline derivatives 3–16. All the synthesized compounds were evaluated for in vitro antimicrobial potential against various bacteria and fungi strains that showed considerable antimicrobial activity against tested microorganisms. The most potent compounds 2, 7, 9, 10, 12 and 13c were exhibited bactericidal activity, in addition to fungistatic activity by dead live assay. Moreover, these compounds showed a significant result against all multi-drug resistance (MDRB) used especially compound 13c that displayed the best results with MICs of MDRB (1.95, 3.9, 2.6, 3.9 µg/mL) for stains used in this study, compared with Norfloxacin (1.25, 0.78, 1.57, 3.13 µg/mL). Also, cytotoxicity on normal cell (Vero cells ATCC CCL-81) by MTT assay was performed with lower toxicity results. Additionally, morphological studies, immunostimulatory potency and DNA gyrase inhibition assay of most active compounds was done. A molecular docking study has also been carried out to support the effective binding of the most promising compounds at the active site of the target enzyme S. aureus DNA gyrase (2XCT).
Heteroleptic Ni<sup>II</sup> complexes: Synthesis, structural characterization, computational studies and amoebicidal activity evaluation
2020, Journal of Inorganic Biochemistry
In this work, we present the synthesis, characterization, electrochemical studies, DFT calculations, and in vitro amoebicidal effect of seven new heteroleptic Ni^II coordination compounds. The crystal structures of [H₂(pdto)](NO₃)₂ and [Ni(pdto)(NO₃)]PF₆ are presented, pdto = 2,2′-[1,2-ethanediylbis-(sulfanediyl-2,1-ethanediyl)]dipyridine. The rest of the compounds have general formulae: [Ni(pdto)(NN)](PF₆) where N-N = 2,2′-bipyridine (bpy), 4,4′-dimethyl-2,2′-bipyridine (44dmbpy), 5,5′-dimethyl-2,2′-bipyridine (55dmbpy), 1,10-phenanthroline (phen), 4,7-dimethyl-1,10-phenanthroline (47dmphen) and 5,6-dimethyl-1,10-phenanthroline (56dmphen). The size of NN ligand and its substituents modulate the compound electronic features and influence their antiproliferative efficiency against Entamoeba histolytica. 56dmphen derivative, shows the biggest molar volume and presents a powerful amoebicidal activity (IC₅₀ = 1.2 μM), being seven times more effective than the first-line drug for human amoebiasis metronidazole. Also, increases the reactive oxygen species concentration within the trophozoites. This could be the trigger of the E. histolytica growth inhibition. The antiparasitic effect is described using Ni^II electron density, molar volume, estimated by DFT, as well as the experimental redox potential and diffusion coefficients. In general, amoebicidal efficiency is directly proportional to the increment of the molar volume and decreases when the redox potential becomes more positive.
Ferrocene derivatives as anti-infective agents
2019, Coordination Chemistry Reviews
Infectious diseases like malaria, tuberculosis or HIV are among the leading causes of death worldwide according to WHO estimations. Nevertheless, the fight against infectious diseases is aggravated through growing development of resistance towards current drugs and due to their severe adverse effects. The introduction of the lipophilic organometallic moiety ferrocene, a compound with a sandwich-like structure, in an existing bioactive molecule is a promising tool for the development of new more efficient drugs with innovative mechanisms of action. Thus, this review summarizes recent developments in the field of ferrocene conjugation to bioactive molecules like natural products, synthetically derived drugs, peptides as well as heterobimetallic complexes. Hereby, we will provide the reader with a summary of the most potent ferrocene derivatives reported for a plethora of infectious diseases by tabulating and critically assessing the corresponding IC₅₀ values and the minimal inhibitory concentrations (MIC). Owing to the diverse field of infectious diseases the reported ferrocene derivatives were classified according to their targets into four main groups: antiparasitic (with antimalarial agents as biggest group), antibacterial, antifungal and antiviral agents.
Synthesis, antiamoebic activity and docking studies of metronidazole-triazole-styryl hybrids
2018, European Journal of Medicinal Chemistry
A series of 22 novel metronidazole-triazole-styryl hybrids were synthesized and evaluated for their in vitro antiamoebic activity against HM1: IMSS strain of Entamoeba histolytica. Some of the hybrids were found to be more active (IC₅₀ = 0.12–0.35 μM) than the reference drug metronidazole (IC₅₀ = 1.79 μM). The most active compounds were found to be non-toxic (up to 50 μM) against the Vero cells showing a good safety profile of these hybrids. The docking and ADMET studies were also conducted to investigate the probable mode of action. Docking studies showed significant binding affinity in the active site of E. histolytica thioredoxin reductase (EhTrR) protein.
Design, synthesis and biological evaluation of quinazolin-4(3H)-one Schiff base conjugates as potential antiamoebic agents
2018, Journal of Saudi Chemical Society
In an effort to develop novel antiamoebic scaffolds having better efficacy than the standard drug metronidazole (IC₅₀ = 1.80 μM) used against Entamoeba histolytica, quinazolin-4(3H)-one Schiff base conjugates were synthesized and evaluated against HM1: IMSS strain of E. histolytica. Out of the thirteen compounds (S2-S14), six compounds (S2, S3, S4, S5, S6 and S11) were found to be better inhibitors than metronidazole and showed low cytotoxicity on HeLa cells, a cervical cancer cell line. The structure of intermediate compound S1 was confirmed by crystal structure studies.
Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives
2017, Bioorganic and Medicinal Chemistry
The 7-benzylidenenaltrexone (BNTX) derivatives 2a–v, 3a–c, 13a–c, and 14a were synthesized from naltrexone (1) and evaluated for their antitrichomonal activity. The structure-activity-relationship studies found that 4-iodo-BNTX (2g) showed the highest activity (IC₅₀ = 10.5 µM) and the affinity for the opioid receptor was less important for antitrichomonal activity against Trichomonas vaginalis. The morphinan skeleton bearing both the double bond for a Michael acceptor and the phenolic hydroxy group would be a specific template for development of antitrichomonal agents. In addition, the mechanism of the antitrichomonal activity of the BNTX derivatives may differ from that of the standard drug, metronidazole.

View all citing articles on Scopus

View full text

ReviewMetronidazole and drug resistance

Abstract

Biochem. Pharmacol.

Biochem. Pharmacol.

Mol. Biochem. Parasitol.

Mol. Biochem. Parasitol.

Biochem. Pharmacol.

Biochem. Pharmacol.

Biochem. Pharmacol.

J. Biol. Chem.

J. Biol. Chem.

J. Biol, Chem.

Plasmid

Plasmid

Internatl J. Parasitol.

Mol. Biochem. Parasitol.

Cell

J. Biol. Chem.

Mol. Biochem. Parasitol.

Adv. Cancer Res.

Surgery

Br. J. Radial.

Radiat. Res.

Annu. Rev. Med.

N. Engl. J. Med.

Review
Metronidazole and drug resistance